Heart Failure

Latest Features

Managing Heart Failure: Improving Quality of Life and Preventing Excerbations

Managing Heart Failure: Improving Quality of Life and Preventing Excerbations

Heart failure is the number 1 reason for patient re-admittance to acute-care facilities according to the American Heart Association.

Preventing Heart Failure One Risk Factor at a Time

Preventing Heart Failure One Risk Factor at a Time

Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.

Hope for Heart Failure in Thyroid Hormone Therapy

Hope for Heart Failure in Thyroid Hormone Therapy

Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.

Premature Ventricle Contractions in Heart Failure: A Closer Examination

Premature Ventricle Contractions in Heart Failure: A Closer Examination

A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.

Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"

Clinician Viewpoints on the "2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure"

Drs Tauras and Patel from Montefiore Medical Center in the Bronx, New York weigh in on what the new heart failure therapeutic guidelines mean for practicing clinicians.

Managing Cardiovascular Complications of Oncology Treatment

Managing Cardiovascular Complications of Oncology Treatment

Clinicians seek stronger collaboration between cardiology and oncology as well as evidence-based treatment guidelines.

Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure

Ixmyelocel-T Cell-Based Therapy Reduced Cardiac Events in Heart Failure

Ixmyelocel-T therapy reduced clinical cardiac events and improved patient outcomes.

Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD

Better Late Than Never: Exercise as Primary and Secondary Prevention in CVD

Exercise's potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.

Heart Failure Patients Rarely Use Evidence-Based Alternative Treatments

Heart Failure Patients Rarely Use Evidence-Based Alternative Treatments

Patients with heart failure rarely use evidence-based alternative treatments such as yoga or massage, to manage their comorbid chronic pain.

Latest News

Spironolactone Oral Suspension Formulation Approved by FDA

Spironolactone Oral Suspension Formulation Approved by FDA

The FDA has approved CaroSpir, the first oral liquid formulation of spironolactone for hypertension and heart failure treatment.

Beta-Blockers Reduce CV Mortality in Heart Failure With Preserved Ejection Fraction

Beta-Blockers Reduce CV Mortality in Heart Failure With Preserved Ejection Fraction

Most pharmacotherapies appear not to have significant effect on all-cause or cardiovascular mortality in heart failure with preserved ejection fraction.

Gene Editing May Provide New Treatment Option for Hypertrophic Cardiomyopathy

Gene Editing May Provide New Treatment Option for Hypertrophic Cardiomyopathy

Researchers have used a gene-editing tool to repair the segment of DNA that causes hypertrophic cardiomyopathy.

Heart Failure in Type 2 Diabetes: Improving the Risk Model

Heart Failure in Type 2 Diabetes: Improving the Risk Model

N-terminal pro-B-type natriuretic peptide showed the strongest association with heart failure in patients with type 2 diabetes.

Childhood Asthma Linked With Increased Left Ventricular Mass In Adulthood

Childhood Asthma Linked With Increased Left Ventricular Mass In Adulthood

Greater left ventricle mass and left ventricle mass indexed to height were found in participants with a history of childhood asthma.

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

In patients with acute myocardial infarction without heart failure, beta-blockers did not reduce mortality risk at 1 year.

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.

Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation

Exercise Capacity in Heart Failure With Reduced Ejection Fraction Not Improved With Iron Supplementation

Patients with heart failure with reduced ejection fraction and iron deficiency do not benefit from iron supplementation.

Acute Heart Failure Mortality Increased With Morphine

Acute Heart Failure Mortality Increased With Morphine

Patients with acute heart failure who received intravenous morphine in the emergency department had higher mortality compared with patients who did not receive morphine.

Heart Failure Risk Increased With Fewer Menstrual Cycles

Heart Failure Risk Increased With Fewer Menstrual Cycles

Women with fewer menstrual cycles are at a higher risk for incident heart failure.

Sign Up for Free e-Newsletters